EP2251048A2 - Artificial eardrum using silk protein and method of fabricating the same - Google Patents
Artificial eardrum using silk protein and method of fabricating the same Download PDFInfo
- Publication number
- EP2251048A2 EP2251048A2 EP09164040A EP09164040A EP2251048A2 EP 2251048 A2 EP2251048 A2 EP 2251048A2 EP 09164040 A EP09164040 A EP 09164040A EP 09164040 A EP09164040 A EP 09164040A EP 2251048 A2 EP2251048 A2 EP 2251048A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- silk
- silk protein
- eardrum
- membrane
- complex solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 72
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 72
- 210000003454 tympanic membrane Anatomy 0.000 title claims abstract description 63
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 11
- 239000012528 membrane Substances 0.000 claims abstract description 46
- 108010013296 Sericins Proteins 0.000 claims abstract description 17
- 241000255789 Bombyx mori Species 0.000 claims abstract description 14
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 14
- 238000001035 drying Methods 0.000 claims abstract description 9
- 102000008186 Collagen Human genes 0.000 claims abstract description 7
- 108010035532 Collagen Proteins 0.000 claims abstract description 7
- 239000000783 alginic acid Substances 0.000 claims abstract description 7
- 235000010443 alginic acid Nutrition 0.000 claims abstract description 7
- 229920000615 alginic acid Polymers 0.000 claims abstract description 7
- 229960001126 alginic acid Drugs 0.000 claims abstract description 7
- 150000004781 alginic acids Chemical class 0.000 claims abstract description 7
- 229920001436 collagen Polymers 0.000 claims abstract description 7
- 239000000835 fiber Substances 0.000 claims abstract description 7
- 229920001983 poloxamer Polymers 0.000 claims abstract description 7
- 239000000243 solution Substances 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 claims description 20
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 16
- 239000007864 aqueous solution Substances 0.000 claims description 10
- 239000011592 zinc chloride Substances 0.000 claims description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 239000000654 additive Substances 0.000 claims description 9
- 230000000996 additive effect Effects 0.000 claims description 9
- -1 poly(ethylene glycol) Polymers 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 6
- 229920001661 Chitosan Polymers 0.000 claims description 6
- 108010010803 Gelatin Proteins 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- 239000003242 anti bacterial agent Substances 0.000 claims description 6
- 229920000159 gelatin Polymers 0.000 claims description 6
- 239000008273 gelatin Substances 0.000 claims description 6
- 235000019322 gelatine Nutrition 0.000 claims description 6
- 235000011852 gelatine desserts Nutrition 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 230000003196 chaotropic effect Effects 0.000 claims description 5
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 claims description 5
- 235000005074 zinc chloride Nutrition 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 239000000049 pigment Substances 0.000 claims description 3
- 239000004014 plasticizer Substances 0.000 claims description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 3
- 230000003115 biocidal effect Effects 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 238000011109 contamination Methods 0.000 claims 1
- 108010022355 Fibroins Proteins 0.000 abstract description 10
- 230000008929 regeneration Effects 0.000 abstract description 9
- 238000011069 regeneration method Methods 0.000 abstract description 9
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 206010045210 Tympanic Membrane Perforation Diseases 0.000 description 14
- 239000000463 material Substances 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 238000003306 harvesting Methods 0.000 description 4
- 239000012460 protein solution Substances 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 238000010171 animal model Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 210000003195 fascia Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 241000228257 Aspergillus sp. Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000012237 artificial material Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 201000001031 chronic tympanitis Diseases 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001523 electrospinning Methods 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002121 nanofiber Substances 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000007669 thermal treatment Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F11/00—Methods or devices for treatment of the ears or hearing sense; Non-electric hearing aids; Methods or devices for enabling ear patients to achieve auditory perception through physiological senses other than hearing sense; Protective devices for the ears, carried on the body or in the hand
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/18—Internal ear or nose parts, e.g. ear-drums
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/18—Internal ear or nose parts, e.g. ear-drums
- A61F2002/183—Ear parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/14—Materials or treatment for tissue regeneration for ear reconstruction or ear implants, e.g. implantable hearing aids
Definitions
- the present invention relates to an artificial eardrum using silk protein and a method of fabricating the same, and more particularly, to an artificial eardrum using silk protein having a form of a silk membrane using silk protein or a complex thereof obtained by removing sericin from a silkworm cocoon as a material for the artificial eardrum, which stimulates regeneration of an eardrum perforated due to disease or a sudden accident, provides a clean boundary of the regenerated eardrum, and is easy to use due to high biocompatibility and transparency, and a method of fabricating the same.
- silk is a fabric made from silkworm cocoons spun by silkworms raised on mulberry leaves, and has been used as a material for high quality fabric for several thousand years due to its unique shine, good dyeing property, high tensile strength, smooth texture and elegant sound when brushed against.
- the silk is composed of two strands of fibroin and sericin surrounding the fibroin, and generally refers to the fibroin that remains after removal of the sericin. Since silk fibroin has no bad influence upon tissues existing therearound due to high biocompatibility, it is manufactured in powders, gels and aqueous solutions and thus applied to various fields such as foods, cosmetics and the like.
- silk fibroin is known to have effects in proliferation and activation of epidermal cells originating from human bodies, and thus has been discussed with regard to use for cosmetic materials (Korean Patent Publication No. 2001-52075 ), wound dressing (Korean Patent Publication Nos. 1999-7001234 and 2000-51938 ), and electrospinning nanofiber non-woven fabrics (Korean Patent Publication No. 2004-0011786 , and U.S. Patent Publication No. 6,110,590 ).
- no silk materials for an artificial eardrum have been disclosed.
- myringoplasty and patches stimulate regeneration of an eardrum perforated due to trauma or inflammation.
- the myringoplasty helps an epithelium of an eardrum to grow at a perforated site using autogenous fascia or other soft tissues.
- An eardrum patch induces regeneration of a planar epithelium layer along the patch by applying the patch to completely contact a perforated peripheral portion of the eardrum, and thus increases a therapeutic success for a short period of time without complications.
- This method has been frequently used for treating traumatic eardrum perforation since it was suggested by Blake in 1887.
- This method does not involve replacing the perforated eardrum with an artificial eardrum, but naturally helping to block the perforated eardrum by applying a patch to the perforated site of the eardrum.
- the regenerated eardrum is grown along the patch-applied site.
- the present invention is directed to an artificial eardrum using silk protein having a form of a silk membrane using silk protein or a complex thereof obtained by removing sericin from a silkworm cocoon as a material for the artificial eardrum, which stimulates regeneration of an eardrum perforated due to disease or a sudden accident, provides a clean boundary of the regenerated eardrum, and is easy to use due to high biocompatibility and transparency, and a method of fabricating the same.
- an artificial eardrum using silk protein which is fabricated into a silk membrane by desalinating and drying silk protein or a complex solution thereof which is obtained after removal of sericin from a cocoon or fibroin.
- the silk membrane may be fabricated using silk protein or a silk protein complex solution with a concentration of 0.8 to 20% at room temperature to 90 °C.
- the silk protein or silk protein complex solution may be dissolved using a chaotropic salt composed of at least one compound or an ethanol aqueous solution including the same selected from lithium bromide (LiBr), lithium chloride (LiCl 2 ), zinc chloride (ZnCl 2 ) and calcium chloride (CaCl 2 ).
- a chaotropic salt composed of at least one compound or an ethanol aqueous solution including the same selected from lithium bromide (LiBr), lithium chloride (LiCl 2 ), zinc chloride (ZnCl 2 ) and calcium chloride (CaCl 2 ).
- the silk membrane may further include at least one additive selected from gelatin, collagen, chitosan, alginic acid, hyarulonic acid, pluronic 127 and poly(ethylene glycol) (PEG).
- at least one additive selected from gelatin, collagen, chitosan, alginic acid, hyarulonic acid, pluronic 127 and poly(ethylene glycol) (PEG).
- the silk membrane may further include at least one additive selected from a plasticizer, a softner, an antibiotic, an antibacterial agent, a cell, an enzyme, an antibody and a pigment or a combination thereof to prevent additional infection at a silk membrane-applied site.
- at least one additive selected from a plasticizer, a softner, an antibiotic, an antibacterial agent, a cell, an enzyme, an antibody and a pigment or a combination thereof to prevent additional infection at a silk membrane-applied site.
- a method of fabricating an artificial eardrum using silk protein includes: (a) preparing silk protein or a silk protein complex solution after removal of sericin from a cocoon or fibroin; and (b) desalinating and drying the prepared silk protein or silk protein complex solution to fabricate the prepared silk protein or silk protein complex solution into a silk membrane.
- the silk protein or silk protein complex solution may be dissolved using a chaotropic salt composed of at least one compound selected from lithium bromide (LiBr), lithium chloride (LiCl 2 ), zinc chloride (ZnCl 2 ) and calcium chloride (CaCl 2 ) or an ethanol aqueous solution including the same.
- a chaotropic salt composed of at least one compound selected from lithium bromide (LiBr), lithium chloride (LiCl 2 ), zinc chloride (ZnCl 2 ) and calcium chloride (CaCl 2 ) or an ethanol aqueous solution including the same.
- the silk membrane may be recrystallized by heat treatment or solvent treatment to reduce solubility to water.
- the solvent may be at least one alcohol of methanol, ethanol and propanol or an aqueous solution thereof.
- a concentration of the silk protein or silk protein complex solution prepared in step (a) may be controlled using PEG or by drying under reduced pressure using a drier or vacuum drier.
- the silk membrane fabricated in step (b) may include at least one additive of gelatin, collagen, chitosan, alginic acid, hyarulonic acid, pluronic 127 and PEG.
- an artificial eardrum using silk protein of the present invention is an artificial biological membrane which is fabricated using a silk material and useful for acute and chronic eardrum perforations.
- the artificial eardrum may include artificial biological membranes using silk as well as patches for the eardrum.
- FIG. 1 is a silk membrane for an artificial eardrum using silk protein and a fractured surface thereof according to an exemplary embodiment of the present invention
- FIG. 2 is an exemplary tensile strength curve of a silk membrane for an artificial eardrum using silk protein according to an exemplary embodiment of the present invention.
- an artificial eardrum using silk protein is fabricated into a silk membrane using silk protein (or silk fibroin) or a silk protein complex obtained after removal of sericin from a cocoon or silk fiber.
- the silk membrane for an artificial eardrum may be fabricated to a thickness of about 30 to 200 ⁇ m by properly controlling a concentration of the silk protein and a membrane fabrication temperature.
- a silk artificial eardrum may have a thickness of about 80 to 120 ⁇ m.
- the artificial eardrum of the present invention may effectively regenerate a damaged artificial eardrum due to its transparency, excellent cellular compatibility and biocompatibility, and prevention of invasion of bacteria from outside.
- a damaged tissue may be effective in the regeneration of an eardrum.
- the artificial eardrum fabricated using silk protein exhibits significant recovery of the artificial eardrum after 3 days of an operation.
- the artificial eardrum of the present invention may further include at least one additive of gelatin, collagen, chitosan, alginic acid, hyarulonic acid, pluronic 127 and poly(ethylene glycol) (PEG) to be manageable in a dry state.
- gelatin collagen, chitosan, alginic acid, hyarulonic acid, pluronic 127 and poly(ethylene glycol) (PEG) to be manageable in a dry state.
- the artificial eardrum of the present invention may further include at least one additive selected from the group consisting of plasticizers, softeners, antibiotics, antibacterial agents, cells, enzymes, antibodies and pigments and combinations thereof.
- an artificial eardrum using silk protein is a silk membrane fabricated using silk protein or a silk protein complex solution with a concentration of 0.8 to 20% obtained after removal of sericin from a cocoon or silk fiber at room temperature to 90 °C.
- the silk membrane fabricated according to an exemplary embodiment of the present invention may be recrystallized to reduce solubility to water.
- the method used for recrystallization may be thermal treatment or solvent treatment.
- the solvent may include any of C 1 to C 3 alcohols such as methanol, ethanol and propanol, or an aqueous solution thereof.
- a process of removing sericin from a cocoon or raw silk refers to degumming.
- degumming processes are well known to those skilled in the art.
- examples of the degumming processes include a method of boiling Marseille soap, sodium carbonate and the like in an alkali aqueous solution, a degumming method using a protease extracted from Aspergillus sp. and the like, and a high temperature high pressure method using a high temperature and high pressure pot. If a subsequent process is continued without the removal of sericin, many bubbles may be generated, which may cause considerable amounts of problems in processes.
- the silk protein (or silk fibroin) from which sericin is removed is fabricated by being dissolved in a chaotropic salt that is known to dissolve protein.
- Neutral salts used in fabrication of the silk protein solution are also well known.
- a degummed cocoon or fiber or fabrics is dissolved in an ethanol aqueous solution containing lithium bromide (LiBr), lithium chloride (LiCl 2 ), zinc chloride (ZnCl 2 ) or calcium chloride (CaCl 2 ), and then the resulting solution is dialyzed using a dialysis membrane such as cellophane, thereby completely removing the neutral salt.
- the silk protein solution may properly control conditions dissolving the silk protein, a concentration and a dry temperature, thereby properly controlling a thickness of the silk membrane for the artificial eardrum in a range from about 30 to 200 ⁇ m.
- PEG may be used or drying under reduced pressure may be performed using a dryer or vacuum dryer.
- the fabricated silk membrane may include at least one additive of gelatin, collagen, chitosan, alginic acid, hyarulonic acid, pluronic 127 and PEG.
- FIG. 3 is a photograph in which a membrane patch fabricated using silk protein of the present invention is applied to a perforated eardrum in an animal model
- FIG. 4 is a histological result of the membrane fabricated using silk protein of the present invention, which is obtained from an animal having a perforated eardrum
- FIG. 5 is a graph and chart of a histological result of a membrane fabricated using silk protein of the present invention, which is obtained from an animal having a perforated eardrum.
- a silkworm cocoon is carefully selected after a contaminated portion, for example, by silkworm excretions, is removed, and then immersed in water having a weight 100 times that of the cocoon.
- the silkworm cocoon is treated with 0.2% Marseille soap and 0.2% sodium carbonate per material weight two times for about 50 minutes at the boiling point, and then washed with boiling water several times, thereby removing sericin.
- the silkworm cocoon from which sericin is removed is placed in a mixed solvent including calcium chloride, water and ethanol in a molar ratio of 1:8:2 to dissolve at the boiling point for about 3 hours and centrifuged, thereby removing remaining impurities.
- a mixed solvent including calcium chloride, water and ethanol in a molar ratio of 1:8:2 to dissolve at the boiling point for about 3 hours and centrifuged, thereby removing remaining impurities.
- the solution is dialyzed for about 4 days using a cellulose dialysis membrane, thereby fabricating a pure silk protein solution.
- the silk protein solution is dried at a constant temperature of about 60 °C, thereby fabricating a silk membrane.
- a scanning electron microscope as shown in FIG. 1 , it can be confirmed that a nonporous, transparent and smooth silk membrane is fabricated.
- the mechanical strength of the silk membrane is obtained by measurements repeated at least about 10 times after conditioning for about 48 hours at a relative humidity of about 65% at room temperature, which are standard conditions.
- An average breaking strength of the silk membrane is about 10 MPa, and this is similar to about 12.5 MPa which is a breaking strength of a paper patch generally used.
- a contact angle is measured using a contact angle measurer (Kruss easydrop), and is in a range from about 45 to 55°.
- the silk membrane is preferable for regeneration of an eardrum.
- the artificial eardrum is fabricated into a silk membrane by desalinating and drying silk protein or a silk protein complex solution obtained after removal of sericin from a silkworm cocoon or silk fiber.
- the artificial eardrum stimulates regeneration of an eardrum perforated due to disease or a sudden accident, thereby providing a clean boundary of the regenerated eardrum, and advantages of biocompatibility and transparency.
- the present invention can reduce occurrence of donor harvesting operations which may be performed due to autograft, and thus not only avoid complications due to the donor harvesting operations, but also reduce complications compared with conventional artificial materials due to high biocompatibility.
- short operation time and speedy post-surgical recovery can be provided to a patient, which are useful for both patients and doctors.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Otolaryngology (AREA)
- Zoology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Acoustics & Sound (AREA)
- Biophysics (AREA)
- Psychology (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
Abstract
Description
- This application claims the benefit of Korean Patent Application No.
2009-0040200, filed on May 8, 2009 - The present invention relates to an artificial eardrum using silk protein and a method of fabricating the same, and more particularly, to an artificial eardrum using silk protein having a form of a silk membrane using silk protein or a complex thereof obtained by removing sericin from a silkworm cocoon as a material for the artificial eardrum, which stimulates regeneration of an eardrum perforated due to disease or a sudden accident, provides a clean boundary of the regenerated eardrum, and is easy to use due to high biocompatibility and transparency, and a method of fabricating the same.
- Generally, silk is a fabric made from silkworm cocoons spun by silkworms raised on mulberry leaves, and has been used as a material for high quality fabric for several thousand years due to its unique shine, good dyeing property, high tensile strength, smooth texture and elegant sound when brushed against.
- The silk is composed of two strands of fibroin and sericin surrounding the fibroin, and generally refers to the fibroin that remains after removal of the sericin. Since silk fibroin has no bad influence upon tissues existing therearound due to high biocompatibility, it is manufactured in powders, gels and aqueous solutions and thus applied to various fields such as foods, cosmetics and the like.
- In addition, silk fibroin is known to have effects in proliferation and activation of epidermal cells originating from human bodies, and thus has been discussed with regard to use for cosmetic materials (Korean Patent Publication No.
2001-52075 1999-7001234 2000-51938 2004-0011786 U.S. Patent Publication No. 6,110,590 ). However, no silk materials for an artificial eardrum have been disclosed. - Meanwhile, conventional myringoplasty and patches stimulate regeneration of an eardrum perforated due to trauma or inflammation. Particularly, the myringoplasty helps an epithelium of an eardrum to grow at a perforated site using autogenous fascia or other soft tissues.
- However, to harvest autogenous fascia and soft tissues, a donor harvesting operation is needed, which may cause inflammations and scars, and an increase in operation time.
- An eardrum patch induces regeneration of a planar epithelium layer along the patch by applying the patch to completely contact a perforated peripheral portion of the eardrum, and thus increases a therapeutic success for a short period of time without complications. This method has been frequently used for treating traumatic eardrum perforation since it was suggested by Blake in 1887.
- This method does not involve replacing the perforated eardrum with an artificial eardrum, but naturally helping to block the perforated eardrum by applying a patch to the perforated site of the eardrum. The regenerated eardrum is grown along the patch-applied site.
- However, conventional materials for an eardrum patch are usually paper patches, which are not very efficient or compatible due to long regeneration time and a thickness of the regenerated eardrum.
- If the perforated eardrum is left for a long period of time, chronic tympanitis may occur. It is known that a paper patch is generally used to treat the chronic eardrum perforation, but it can cause inflammation. Moreover, it is expected that it will not be easy to regenerate the perforated eardrum as senior population is increased due to aging society, and thus it is urgent to develop and market novel products for artificial eardrums.
- The present invention is directed to an artificial eardrum using silk protein having a form of a silk membrane using silk protein or a complex thereof obtained by removing sericin from a silkworm cocoon as a material for the artificial eardrum, which stimulates regeneration of an eardrum perforated due to disease or a sudden accident, provides a clean boundary of the regenerated eardrum, and is easy to use due to high biocompatibility and transparency, and a method of fabricating the same.
- According to an aspect of the present invention, there is provided an artificial eardrum using silk protein which is fabricated into a silk membrane by desalinating and drying silk protein or a complex solution thereof which is obtained after removal of sericin from a cocoon or fibroin.
- Here, the silk membrane may be fabricated using silk protein or a silk protein complex solution with a concentration of 0.8 to 20% at room temperature to 90 °C.
- The silk protein or silk protein complex solution may be dissolved using a chaotropic salt composed of at least one compound or an ethanol aqueous solution including the same selected from lithium bromide (LiBr), lithium chloride (LiCl2), zinc chloride (ZnCl2) and calcium chloride (CaCl2).
- The silk membrane may further include at least one additive selected from gelatin, collagen, chitosan, alginic acid, hyarulonic acid, pluronic 127 and poly(ethylene glycol) (PEG).
- The silk membrane may further include at least one additive selected from a plasticizer, a softner, an antibiotic, an antibacterial agent, a cell, an enzyme, an antibody and a pigment or a combination thereof to prevent additional infection at a silk membrane-applied site.
- According to another aspect of the present invention, a method of fabricating an artificial eardrum using silk protein includes: (a) preparing silk protein or a silk protein complex solution after removal of sericin from a cocoon or fibroin; and (b) desalinating and drying the prepared silk protein or silk protein complex solution to fabricate the prepared silk protein or silk protein complex solution into a silk membrane.
- Here, after step (a), the silk protein or silk protein complex solution may be dissolved using a chaotropic salt composed of at least one compound selected from lithium bromide (LiBr), lithium chloride (LiCl2), zinc chloride (ZnCl2) and calcium chloride (CaCl2) or an ethanol aqueous solution including the same.
- After step (b), the silk membrane may be recrystallized by heat treatment or solvent treatment to reduce solubility to water.
- The solvent may be at least one alcohol of methanol, ethanol and propanol or an aqueous solution thereof.
- A concentration of the silk protein or silk protein complex solution prepared in step (a) may be controlled using PEG or by drying under reduced pressure using a drier or vacuum drier.
- The silk membrane fabricated in step (b) may include at least one additive of gelatin, collagen, chitosan, alginic acid, hyarulonic acid, pluronic 127 and PEG.
- These and/or other objects, aspects and advantages of the invention will become apparent and more readily appreciated from the following description of the exemplary embodiments, taken in conjunction with the accompanying drawings of which:
-
FIG. 1 is a silk membrane for an artificial eardrum using silk protein and a fractured surface thereof according to an exemplary embodiment of the present invention; -
FIG. 2 is an exemplary tensile strength curve of a silk membrane for an artificial eardrum using silk protein according to an exemplary embodiment of the present invention; -
FIG. 3 is a photograph in which a membrane patch fabricated using silk protein of the present invention is applied to a perforated eardrum in an animal model; -
FIG. 4 is a histological result of the membrane fabricated using silk protein of the present invention, which is obtained from an animal having a perforated eardrum; and -
FIG. 5 is a graph and chart of a histological result of the membrane fabricated using silk protein of the present invention, which is obtained from an animal having a perforated eardrum. - Reference will now be made in detail to exemplary embodiments of the present invention, examples of which are shown in the accompanying drawings. However, it should be understood that the present invention is not limited to the described exemplary embodiments, but includes various modifications, equivalents and alternatives. The exemplary embodiments of the present invention are provided to more fully explain the present invention to those skilled in the art.
- To begin with, an artificial eardrum using silk protein of the present invention is an artificial biological membrane which is fabricated using a silk material and useful for acute and chronic eardrum perforations. The artificial eardrum may include artificial biological membranes using silk as well as patches for the eardrum.
-
FIG. 1 is a silk membrane for an artificial eardrum using silk protein and a fractured surface thereof according to an exemplary embodiment of the present invention, andFIG. 2 is an exemplary tensile strength curve of a silk membrane for an artificial eardrum using silk protein according to an exemplary embodiment of the present invention. - Referring to
FIGS. 1 and2 , an artificial eardrum using silk protein according to an exemplary embodiment of the present invention is fabricated into a silk membrane using silk protein (or silk fibroin) or a silk protein complex obtained after removal of sericin from a cocoon or silk fiber. - Here, the silk membrane for an artificial eardrum may be fabricated to a thickness of about 30 to 200 µm by properly controlling a concentration of the silk protein and a membrane fabrication temperature. In consideration of contact with a perforated eardrum, a mechanical strength of an artificial eardrum and the like, a silk artificial eardrum may have a thickness of about 80 to 120 µm.
- Particularly, the artificial eardrum of the present invention may effectively regenerate a damaged artificial eardrum due to its transparency, excellent cellular compatibility and biocompatibility, and prevention of invasion of bacteria from outside. Thus, even a damaged tissue may be effective in the regeneration of an eardrum. Moreover, according to an example of the present invention, the artificial eardrum fabricated using silk protein exhibits significant recovery of the artificial eardrum after 3 days of an operation.
- The artificial eardrum of the present invention may further include at least one additive of gelatin, collagen, chitosan, alginic acid, hyarulonic acid, pluronic 127 and poly(ethylene glycol) (PEG) to be manageable in a dry state.
- The artificial eardrum of the present invention may further include at least one additive selected from the group consisting of plasticizers, softeners, antibiotics, antibacterial agents, cells, enzymes, antibodies and pigments and combinations thereof.
- Hereinafter, a method of fabricating an artificial eardrum using silk protein according to an exemplary embodiment of the present invention will be described in detail.
- To begin with, an artificial eardrum using silk protein according to an exemplary embodiment of the present invention is a silk membrane fabricated using silk protein or a silk protein complex solution with a concentration of 0.8 to 20% obtained after removal of sericin from a cocoon or silk fiber at room temperature to 90 °C.
- Here, the silk membrane fabricated according to an exemplary embodiment of the present invention may be recrystallized to reduce solubility to water. The method used for recrystallization may be thermal treatment or solvent treatment. The solvent may include any of C1 to C3 alcohols such as methanol, ethanol and propanol, or an aqueous solution thereof.
- Meanwhile, a process of removing sericin from a cocoon or raw silk refers to degumming. Such degumming processes are well known to those skilled in the art. For example, examples of the degumming processes include a method of boiling Marseille soap, sodium carbonate and the like in an alkali aqueous solution, a degumming method using a protease extracted from Aspergillus sp. and the like, and a high temperature high pressure method using a high temperature and high pressure pot. If a subsequent process is continued without the removal of sericin, many bubbles may be generated, which may cause considerable amounts of problems in processes.
- The silk protein (or silk fibroin) from which sericin is removed is fabricated by being dissolved in a chaotropic salt that is known to dissolve protein. Neutral salts used in fabrication of the silk protein solution are also well known. For example, a degummed cocoon or fiber or fabrics is dissolved in an ethanol aqueous solution containing lithium bromide (LiBr), lithium chloride (LiCl2), zinc chloride (ZnCl2) or calcium chloride (CaCl2), and then the resulting solution is dialyzed using a dialysis membrane such as cellophane, thereby completely removing the neutral salt.
- The silk protein solution may properly control conditions dissolving the silk protein, a concentration and a dry temperature, thereby properly controlling a thickness of the silk membrane for the artificial eardrum in a range from about 30 to 200 µm.
- In addition, to control the concentration of the silk protein or silk protein complex solution, PEG may be used or drying under reduced pressure may be performed using a dryer or vacuum dryer.
- Further, the fabricated silk membrane may include at least one additive of gelatin, collagen, chitosan, alginic acid, hyarulonic acid, pluronic 127 and PEG.
-
FIG. 3 is a photograph in which a membrane patch fabricated using silk protein of the present invention is applied to a perforated eardrum in an animal model,FIG. 4 is a histological result of the membrane fabricated using silk protein of the present invention, which is obtained from an animal having a perforated eardrum, andFIG. 5 is a graph and chart of a histological result of a membrane fabricated using silk protein of the present invention, which is obtained from an animal having a perforated eardrum. - Referring to
FIGS. 3 to 5 , a silkworm cocoon is carefully selected after a contaminated portion, for example, by silkworm excretions, is removed, and then immersed in water having aweight 100 times that of the cocoon. The silkworm cocoon is treated with 0.2% Marseille soap and 0.2% sodium carbonate per material weight two times for about 50 minutes at the boiling point, and then washed with boiling water several times, thereby removing sericin. - The silkworm cocoon from which sericin is removed is placed in a mixed solvent including calcium chloride, water and ethanol in a molar ratio of 1:8:2 to dissolve at the boiling point for about 3 hours and centrifuged, thereby removing remaining impurities. To remove the salt from the dissolved silkworm cocoon solution, the solution is dialyzed for about 4 days using a cellulose dialysis membrane, thereby fabricating a pure silk protein solution.
- The silk protein solution is dried at a constant temperature of about 60 °C, thereby fabricating a silk membrane. When the fabricated silk membrane is observed by a scanning electron microscope as shown in
FIG. 1 , it can be confirmed that a nonporous, transparent and smooth silk membrane is fabricated. - Here, the mechanical strength of the silk membrane is obtained by measurements repeated at least about 10 times after conditioning for about 48 hours at a relative humidity of about 65% at room temperature, which are standard conditions. An average breaking strength of the silk membrane is about 10 MPa, and this is similar to about 12.5 MPa which is a breaking strength of a paper patch generally used.
- In addition, to observe surface characteristics of the silk membrane, after about 5 seconds of dropping distilled water, a contact angle is measured using a contact angle measurer (Kruss easydrop), and is in a range from about 45 to 55°. Thus, the silk membrane is preferable for regeneration of an eardrum.
- According to the aforementioned artificial eardrum and a method of fabricating the same of the present invention, the artificial eardrum is fabricated into a silk membrane by desalinating and drying silk protein or a silk protein complex solution obtained after removal of sericin from a silkworm cocoon or silk fiber. Thus, the artificial eardrum stimulates regeneration of an eardrum perforated due to disease or a sudden accident, thereby providing a clean boundary of the regenerated eardrum, and advantages of biocompatibility and transparency.
- In addition, the present invention can reduce occurrence of donor harvesting operations which may be performed due to autograft, and thus not only avoid complications due to the donor harvesting operations, but also reduce complications compared with conventional artificial materials due to high biocompatibility.
- According to the present invention, it is possible to massively produce eardrums and to fabricate the eardrums in various shapes.
- Moreover, according to the present invention, short operation time and speedy post-surgical recovery can be provided to a patient, which are useful for both patients and doctors.
- Although a few embodiments of the present invention have been shown and described, it would be appreciated by those skilled in the art that changes may be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the claims and their equivalents.
Claims (11)
- An artificial eardrum using silk protein which is fabricated into a silk membrane by desalinating and drying silk protein or a silk protein complex solution obtained after removal of sericin from a silkworm cocoon or silk fiber.
- The artificial eardrum of claim 1, wherein the silk membrane is fabricated using silk protein or a silk protein complex solution having a concentration of 0.8 to 20% at room temperature to 90 °C.
- The artificial eardrum of claim 1, wherein the silk protein or silk protein complex solution is dissolved using a chaotropic salt composed of at least one compound of lithium bromide (LiBr), lithium chloride (LiCl2), zinc chloride (ZnCl2) and calcium chloride (CaCl2) or an ethanol aqueous solution including the same.
- The artificial eardrum of claim 1, wherein the silk membrane further includes at least one additive of gelatin, collagen, chitosan, alginic acid, hyarulonic acid, pluronic 127 and poly(ethylene glycol)(PEG).
- The artificial eardrum of claim 1, wherein the silk membrane further includes at least one additive of a plasticizer, a softner, an antibiotic, an antibacterial agent, a cell, an enzyme, an antibody, a pigment and a combination thereof to prevent additional contamination of an applied site.
- A method of fabricating an artificial eardrum, comprising:(a) preparing silk protein or a silk protein complex solution after removal of sericin from a silkworm cocoon or silk fiber; and(b) desalinating and drying the prepared silk protein or silk protein complex solution to fabricate the prepared silk protein or silk protein complex solution into a silk membrane.
- The method of claim 6, further comprising, after step (a), dissolving the silk protein or silk protein complex solution using a chaotropic salt composed of at least one compound of lithium bromide (LiBr), lithium chloride (LiCl2), zinc chloride (ZnCl2) and calcium chloride (CaCl2) or an ethanol aqueous solution including the same.
- The method of claim 6, further comprising, after step (b), recrystallizing the silk membrane using heat treatment or solvent treatment to reduce solubility to water.
- The method of claim 8, wherein the solvent is at least one alcohol selected from methanol, ethanol and propanol or an aqueous solution thereof.
- The method of claim 6, wherein a concentration of the silk protein or silk protein complex solution prepared in step (a) is controlled using poly(ethylene glycol)(PEG) or by drying under reduced pressure using a drier or vacuum drier.
- The method of claim 6, wherein the silk membrane fabricated in step (b) includes at least one additive of gelatin, collagen, chitosan, alginic acid, hyarulonic acid, pluronic 127 and PEG.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090040200A KR101060910B1 (en) | 2009-05-08 | 2009-05-08 | Artificial tympanum using silk protein and its manufacturing method |
Publications (3)
Publication Number | Publication Date |
---|---|
EP2251048A2 true EP2251048A2 (en) | 2010-11-17 |
EP2251048A3 EP2251048A3 (en) | 2011-09-07 |
EP2251048B1 EP2251048B1 (en) | 2014-04-09 |
Family
ID=42646319
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP09164040.9A Active EP2251048B1 (en) | 2009-05-08 | 2009-06-29 | Artificial eardrum using silk protein and method of fabricating the same |
Country Status (5)
Country | Link |
---|---|
US (1) | US8500808B2 (en) |
EP (1) | EP2251048B1 (en) |
JP (1) | JP5246878B2 (en) |
KR (1) | KR101060910B1 (en) |
CN (1) | CN101879098B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103341209A (en) * | 2013-07-08 | 2013-10-09 | 苏州大学 | Silk fibroin nanofiber membrane and preparation method thereof |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101322337B1 (en) * | 2010-12-23 | 2013-10-25 | 대한민국 | Silk artificial membrane for artificial dural membrane and biological membrane with excellent flexibility and solidity |
AU2012283753B2 (en) * | 2011-07-11 | 2014-12-18 | Ear Science Institute Australia | Device for ear drum repair |
TWI448296B (en) * | 2012-05-04 | 2014-08-11 | Wen Fu Lai | Pharmaceutical composition for repairing eardrum and usage thereof |
CA2876064C (en) | 2012-06-12 | 2020-07-07 | Orthocell Ltd | Method for producing a collagen membrane and uses thereof |
EP2712955A1 (en) | 2012-09-27 | 2014-04-02 | Ludwig Boltzmann Gesellschaft GmbH | Product made of silk |
CN103114491A (en) * | 2013-02-27 | 2013-05-22 | 盐城纺织职业技术学院 | Glue-containing fiber film-forming method and glue-containing fiber film-forming device |
CN103341214B (en) * | 2013-07-08 | 2014-12-31 | 苏州大学 | Silk fibroin membrane and preparation method thereof |
KR101573838B1 (en) * | 2014-06-13 | 2015-12-07 | 대한민국 | Artificial biomembrane using Cocoon and Method for manufacturing thereof |
KR101570717B1 (en) | 2014-08-04 | 2015-11-24 | 대한민국 | Dental Membrain using Cocoon and Method for manufacturing thereof |
KR101629204B1 (en) | 2014-08-19 | 2016-06-10 | 전북대학교산학협력단 | Thin Film Silk fibroin/collagen composite implant and Preparation Method Thereof |
KR101640499B1 (en) * | 2015-08-19 | 2016-07-18 | 한림대학교 산학협력단 | Manufacturing method of fluorescent biomaterials using silk fibroin solution from transgenic silkworm |
KR101602797B1 (en) * | 2015-10-21 | 2016-03-11 | 대한민국 | Artificial biomembrane using silk matrix and Method for manufacturing thereof |
JP2019512352A (en) * | 2016-03-31 | 2019-05-16 | イアー サイエンス インスティテュート オーストラリア | Improved silk fibroin glycerol membrane |
JP7121658B2 (en) * | 2016-04-14 | 2022-08-18 | イアー サイエンス インスティテュート オーストラリア | Improved Silk Fibroin Biocompatible Polyurethane Membrane |
CN106290325B (en) * | 2016-07-19 | 2019-05-03 | 南通纺织丝绸产业技术研究院 | Fibroin film is preparing the application in humidity sensor |
CN106139246A (en) * | 2016-08-19 | 2016-11-23 | 苏州大学 | A kind of regenerated silk azelon support and preparation method thereof |
CN107510863A (en) * | 2017-08-25 | 2017-12-26 | 张阳 | A kind of compound rush CO2 laser weld pipe and preparation method thereof |
CN107552095A (en) * | 2017-09-17 | 2018-01-09 | 钱景 | The silk three-dimensional porous material and preparation method of carried titanium dioxide Nano Silver |
CN110421915B (en) * | 2019-07-05 | 2021-07-30 | 厦门派恩杰科技有限公司 | Preparation method of protein film with heating and temperature control functions |
KR102228268B1 (en) | 2020-08-13 | 2021-03-16 | 한국실크연구원 | Carbon manufacturing apparatus using silk balls |
CN113209388A (en) * | 2021-03-30 | 2021-08-06 | 复旦大学附属眼耳鼻喉科医院 | Fibrous membrane for transmitting sound and inducing regeneration of tympanic membrane as well as preparation method and application of fibrous membrane |
CN113278170B (en) * | 2021-06-15 | 2021-11-16 | 苏州大学 | Chemically crosslinked hyaluronic acid hydrogel and preparation method and application thereof |
CN114835933A (en) * | 2022-05-20 | 2022-08-02 | 西南大学 | Preparation method of Pluronic high-polymer high-toughness fibroin composite transparent film and product |
WO2024144740A2 (en) * | 2022-12-30 | 2024-07-04 | Yildiz Tekni̇k Üni̇versi̇tesi̇ | Polysaccharide-based artificial eardrum patch |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20000051938A (en) | 1999-01-28 | 2000-08-16 | 김강권 | Preparation of silk fibroin membrane for wound covering materials |
US6110590A (en) | 1998-04-15 | 2000-08-29 | The University Of Akron | Synthetically spun silk nanofibers and a process for making the same |
KR20010052075A (en) | 1999-06-03 | 2001-06-25 | 노링스이산쇼 산시.곤츄노교기즈츠켄큐쇼쵸가 다이효스루 닛본고쿠 | Method for manufacturing crystalline superfine silk powder |
KR20040011786A (en) | 2002-07-30 | 2004-02-11 | 박원호 | Wound dressing of silk fibroin nanofibers nonwoven and its preparation |
KR20090040200A (en) | 2007-10-19 | 2009-04-23 | 재단법인서울대학교산학협력재단 | Solar cell apparatus based on microlens array and method for fabricating the same |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6485272A (en) * | 1986-12-10 | 1989-03-30 | Ajinomoto Kk | Adhesive |
SE9101853D0 (en) | 1991-06-17 | 1991-06-17 | Jonas Wadstroem | IMPROVED TISSUE ASHESIVE |
US7236086B1 (en) * | 1993-06-14 | 2007-06-26 | Vlt, Inc. | Power converter configuration, control, and construction |
CN1050242C (en) * | 1993-06-14 | 2000-03-08 | Vlt公司 | Power converter configuration, control, and construction |
NO944266L (en) * | 1993-11-15 | 1995-05-16 | Hughes Aircraft Co | Inductive charging system |
US5945130A (en) * | 1994-11-15 | 1999-08-31 | Vlt Corporation | Apparatus for circuit encapsulation |
US5728600A (en) * | 1994-11-15 | 1998-03-17 | Vlt Corporation | Circuit encapsulation process |
US5787569A (en) * | 1996-02-21 | 1998-08-04 | Lucent Technologies Inc. | Encapsulated package for power magnetic devices and method of manufacture therefor |
KR100431659B1 (en) | 1997-06-18 | 2004-05-17 | 독립행정법인농업생물자원연구소 | Wound dressing material containing silk fibroin and sericin as a main component and method for preparing same |
US5994099A (en) * | 1997-12-31 | 1999-11-30 | The University Of Wyoming | Extremely elastic spider silk protein and DNA coding therefor |
ITVR20010098A1 (en) * | 2001-09-11 | 2003-03-11 | Consorzio Per Gli Studi Uni | PROCEDURE FOR OBTAINING SILK FIBROIN HYDROGELS. |
JP3772207B2 (en) | 2002-06-19 | 2006-05-10 | 独立行政法人農業生物資源研究所 | Biodegradable biopolymer material, production method thereof, and functional material comprising the polymer material |
CN1466935A (en) * | 2002-07-10 | 2004-01-14 | 飞 鲁 | Artificial eardrum |
US7361844B2 (en) * | 2002-11-25 | 2008-04-22 | Vlt, Inc. | Power converter package and thermal management |
CN1219921C (en) | 2003-08-09 | 2005-09-21 | 复旦大学 | High-concentration regenerated silk protein aqueous solution and preparation method thereof |
US7187263B2 (en) * | 2003-11-26 | 2007-03-06 | Vlt, Inc. | Printed circuit transformer |
KR100762928B1 (en) * | 2004-10-29 | 2007-10-04 | 재단법인서울대학교산학협력재단 | Nonwoven Nanofibrous Membranes of Silk Fibroin for Guided Bone Tissue Regeneration and Their Preparation Method |
CN100467680C (en) | 2006-07-13 | 2009-03-11 | 苏州大学 | Anti bacteria natural silk composite nano-fiber material and its preparation method |
KR20060108573A (en) | 2006-09-05 | 2006-10-18 | 주식회사 아이웨어 | Wireless communication method and apparatus for multi voice communication on low-rate wireless personal area network |
KR101070411B1 (en) * | 2006-11-03 | 2011-10-06 | 아주대학교산학협력단 | Artificial chitosan patch for eardrum regeneration |
CN101234213A (en) | 2008-02-26 | 2008-08-06 | 浙江理工大学 | Method of preparing insoluble fibroin protein film |
-
2009
- 2009-05-08 KR KR1020090040200A patent/KR101060910B1/en active IP Right Grant
- 2009-06-29 US US12/493,277 patent/US8500808B2/en active Active
- 2009-06-29 EP EP09164040.9A patent/EP2251048B1/en active Active
- 2009-06-29 JP JP2009154428A patent/JP5246878B2/en active Active
- 2009-07-03 CN CN2009101501247A patent/CN101879098B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6110590A (en) | 1998-04-15 | 2000-08-29 | The University Of Akron | Synthetically spun silk nanofibers and a process for making the same |
KR20000051938A (en) | 1999-01-28 | 2000-08-16 | 김강권 | Preparation of silk fibroin membrane for wound covering materials |
KR20010052075A (en) | 1999-06-03 | 2001-06-25 | 노링스이산쇼 산시.곤츄노교기즈츠켄큐쇼쵸가 다이효스루 닛본고쿠 | Method for manufacturing crystalline superfine silk powder |
KR20040011786A (en) | 2002-07-30 | 2004-02-11 | 박원호 | Wound dressing of silk fibroin nanofibers nonwoven and its preparation |
KR20090040200A (en) | 2007-10-19 | 2009-04-23 | 재단법인서울대학교산학협력재단 | Solar cell apparatus based on microlens array and method for fabricating the same |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103341209A (en) * | 2013-07-08 | 2013-10-09 | 苏州大学 | Silk fibroin nanofiber membrane and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
US8500808B2 (en) | 2013-08-06 |
CN101879098B (en) | 2013-12-25 |
JP2010259767A (en) | 2010-11-18 |
KR20100121169A (en) | 2010-11-17 |
EP2251048B1 (en) | 2014-04-09 |
US20100286774A1 (en) | 2010-11-11 |
CN101879098A (en) | 2010-11-10 |
KR101060910B1 (en) | 2011-08-30 |
JP5246878B2 (en) | 2013-07-24 |
EP2251048A3 (en) | 2011-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8500808B2 (en) | Artificial eardrum using silk protein and method of fabricating the same | |
Chouhan et al. | Silk biomaterials in wound healing and skin regeneration therapeutics: From bench to bedside | |
CN103341209B (en) | Silk fibroin nanofiber membrane and preparation method thereof | |
JP5991624B2 (en) | Collagen non-fibrotic molded body and method for producing the same | |
US20080292667A1 (en) | Nonwoven Nanofibrous Membranes of Silk Fibroin for Guided Bone Tissue Regeneration and Their Preparation Method | |
EP0920875A1 (en) | Wound covering material containing silk fibroin and silk sericin as the main components and process for producing the same | |
ITVR20010098A1 (en) | PROCEDURE FOR OBTAINING SILK FIBROIN HYDROGELS. | |
KR101805781B1 (en) | Method for manufacturing of nanofiber for wet wound dressing and nanofiber for wet wound dressing thereby | |
ES2676545T3 (en) | Method to produce a collagen membrane and uses thereof | |
KR101429522B1 (en) | Method for extracting extracelluar matrix from placenta and scaffold for skin wound treatment using material extracted by the same | |
US20150337008A1 (en) | Method for producing fibroin powder from silk products or filaments | |
Bao et al. | Agar/collagen membrane as skin dressing for wounds | |
JP2021169539A (en) | Insolubilization-free silk fibroin material | |
CN107737364A (en) | A kind of wound dressing and preparation method thereof | |
CN105148325B (en) | A kind of new cornea tissue repair materials and preparation method thereof | |
CN115177778A (en) | Composite wound dressing, preparation method and application | |
KR100491705B1 (en) | Wound dressing of silk fibroin nanofibers nonwoven and its preparation | |
KR101182417B1 (en) | Artificial Nanofiber Amnion Membranes and Method of Making The Same | |
WO2002102845A1 (en) | Process for producing silk fibroin-origin functional polypeptide and utilization thereof | |
TWI414323B (en) | Composition film, the process for the production thereof and use thereof | |
KR101406637B1 (en) | Method of fabricating silk fibroin plate and the silk fibroin plate fabricated thereby | |
US20240285828A1 (en) | Composition using fibrotic acellular dermal matrix, and method for preparing same | |
RU2805473C2 (en) | Method of creating and using mycelial scafolds | |
JP2019163244A (en) | Method for producing cocoon protein solution | |
Kweon et al. | Silk fibroin membrane as guided bone regeneration in rat calvarial defects |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA RS |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61F 2/18 20060101ALI20110728BHEP Ipc: A61F 11/00 20060101ALI20110728BHEP Ipc: A61L 27/36 20060101AFI20110728BHEP |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA RS |
|
17P | Request for examination filed |
Effective date: 20120227 |
|
17Q | First examination report despatched |
Effective date: 20120615 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20130912 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: AT Ref legal event code: REF Ref document number: 660970 Country of ref document: AT Kind code of ref document: T Effective date: 20140415 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602009023064 Country of ref document: DE Effective date: 20140522 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 660970 Country of ref document: AT Kind code of ref document: T Effective date: 20140409 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: VDEP Effective date: 20140409 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140409 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140409 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140709 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140809 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140709 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140409 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140710 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140409 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140409 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140409 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140409 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140409 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140409 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140811 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602009023064 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140629 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140409 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140409 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140409 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140409 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140409 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140409 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140409 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20150112 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140409 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602009023064 Country of ref document: DE Effective date: 20150112 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140630 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140630 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140629 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140409 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140409 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 8 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140409 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20090629 Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140409 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 9 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 10 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140409 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20240322 Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20240408 Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240320 Year of fee payment: 16 |